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Objective: Global positioning system (GPS) recordings can provide valid information on walking capacity in patients with
peripheral arterial disease (PAD) and intermittent claudication (IC) during community-based outdoor walking. This
study used GPS to determine the variability of the free-living walking distance between two stops (WDBS), induced by
lower-limb pain, which may exist within a single stroll in PAD patients with IC and the potential associated parameters
obtained from GPS analysis.
Methods: This cross-sectional study of 57 PAD patients with IC was conducted in a university hospital. The intervention
was a 1-hour free-living walking in a flat public park with GPS recording at 0.5 Hz. GPS-computed parameters for each
patient were WDBS, previous stop duration (PSD), cumulated time from the beginning of the stroll, and average walking
speed for each walking bout. The coefficient of variation of each parameter was calculated for patients with the number
of walking bouts (NWB) >5 during their stroll. A multivariate analysis was performed to correlate WDBS with the other
parameters.
Results: Mean (SD) maximal individual WDBS was 1905 (1189) vs 550 (621) meters for patients with NWB <5 vs NWB
> 5, respectively (P< .001). In the 36 patients with NWB> 5, the coefficient of variation for individual WDBS was 43%.
Only PSD and cumulated time were statistically associated with WDBS in 16 and 5 patients, respectively.
Conclusions:A wide short-term variability of WDBS exists and likely contributes to the difficulties experienced by patients
with IC to estimate their maximal walking distance at leisurely pace. Incomplete recovery from a preceding walk, as
estimated through PSD, seems to dominantly account for the WDBS in patients with IC. (J Vasc Surg 2010;51:886-92.)Claudication is generally one of the first symptoms in
peripheral artery disease (PAD). It is frequently assumed
that the different walking distances between two stops
induced by lower-limb pain within a single stroll are rela-
tively stable. In fact, to our knowledge, the variability of
walking distance between two stops (WDBS) that may exist
within a single stroll has never been measured. What is
available is only the reproducibility of maximal walking
distance (MWD) through test-rest experiments.1-6
The study of this short-term variability (changes in
WDBS within a single stroll) could provide interesting
information about some of the issues relating to functional
assessment in PAD patients. Indeed, if such short-term
variability exists, it may contribute to the difficulties expe-
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886rienced by patients with arterial claudication to estimate
their MWD at usual pace, where MWD would be the
highest WDBS within a stroll. This short-term variability
could also at least partly explain the low concordance
between estimated and measured MWD in PAD pa-
tients.7-9
We showed in a previous study10 that global position-
ing system (GPS) recordings, an original approach for
walking studies, could monitor community-based outdoor
walking and provide valid information on walking capacity
in PAD patients. The GPS technique provides useful data
about actual walking in something approaching a real-
world situation. It further allows for the investigations of
new dimensions of walking, such as the short-term variabil-
ity of walking distance, effect of walking speed, and impor-
tance of stop durations, which would hardly be done by
using treadmill testing.
In the present study, we used the previous validated
methodology of GPS data recording and processing10 to
record walking speed and distance for each walking bout,
duration of the stop preceding each walking bout, and
cumulated-time from the onset of walking in PAD patients
undergoing nonsupervised walking strolls. From these re-
cordings and for patients showing multiple walking bouts,
our first goal was to quantify the individual magnitude of
the variability of WDBS within a single stroll. We hypoth-
esized that the short-term variability would be high in most
patients. A secondary goal was to provide insights into
potential GPS-derived parameters that could be associated
with this short-term variability.
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This study was approved by the local scientific and
ethics committees and registered in the American Na-
tional Institute of Health database under reference No.
NCT00485147 (http://www.clinicaltrials.gov).
Studied population and inclusion criteria. Volunteers
were recruited from among the PAD patients referred to
our laboratory for MWD evaluation on the treadmill. Cri-
teria for inclusion are presented in Table I. Eligible patients
were asked to provide signed, informed consent to partici-
pate.
Definition of claudication. The San Diego Claudica-
tion Questionnaire was used to characterize leg symp-
toms.11 Intermittent claudication was defined as fatigue,
discomfort, or pain that occurred in the calf, thigh, or
buttock during effort due to exercise-induced ischemia and
that resolved 10 minutes of rest.12,13
Laboratory measurements. The ankle-brachial index
(ABI) was measured manually at rest. Self-reported MWD
was noted before the treadmill test by patient interview.
Thereafter, the treadmill test was performed with a 10%
grade and 3.2 km/h speed under medical supervision.14,15
Patients were blinded to the distance and time walked and
were encouraged to perform the test for as long as possible.
Treadmill MWD was noted at the end of each test.
Recommendations for the outdoor stroll. All exper-
iments took place in a designated public park that was the
same as in our previous study.10 This public park is flat (no
hills) and free of motorized vehicle traffic, buildings, and
compact trees. During the postprocessing analysis, the use
of amap projection of the patient’s position during the tests
(CartoExploreur, version 3.11.0 build 2.6.6.22, 2006,
Bayo Ltd, France) allowed investigators to ensure that
patients walked into the right place. The walking surface at
the park is stable ground designed for leisure walking.
Likelihood of crowding and distracting influences (eg,
bicyclists, baby carriages) during the study was very limited
because footpaths are sufficiently large and the park is
sufficiently big to avoid crowding. Because experiments
took place during the week, the park was not busy with too
many people.
Recommendations for the stroll were extensively de-
scribed in our previous study.10 In brief, PAD patients were
Table I. Inclusion criteria
● Age 18 years old
● Clinical stability of claudication 3 months
● Ankle-brachial index at rest 0.95
● Ability to walk on treadmill
● No systemic disease limiting exercise other than claudication
● No myocardial infarction 6 months
● No heart disease requiring surgery
● No angina pectoris
● No sustained ventricular arrhythmias
● No abdominal aortic aneurysm 40 mm
● No uncontrolled hypertension
● No inability to participate in the study for any logistic reasonrecommended to:1. Rest for 10 minutes before starting to stroll when arriv-
ing at the park.
2. Walk at a leisurely pace for a minimum of 1 hour
(including stops).
3. Stop when necessary in case of intense claudication pain
rather than voluntarily slow down to avoid pain when
walking discomfort occurred (onset of pain), with no
recommendation about a minimal or maximal duration
of the stops.
To ensure data recording quality, a short post-test
questionnaire was given by the investigator when patients
returned to the hospital. Each patient was asked to report
any unexpected external (eg, dogs, bicycles) or personal
(eg, urinating, answering a phone call) event(s) that may
have led to a walking stop unrelated to limb pain.
GPS data recording and processing. We used the
Garmin GPS 60 (Garmin Ltd, Olathe, Kan) to record the
stroll. Technical details, validation of the recording method,
and data analysis have been previously reported.10,16 In the
present study, stops10 seconds were removed and incorpo-
rated in walking bouts because they were not expected to
induce a significant recovery and could artificially increase
variability. The parameters recorded for each patient were
the total walked distance, the whole duration of the out-
door stroll, the mean walking speed calculated over each
walking bout, the number of walking bouts (NWB), the
various WDBS over each walking bout, and the duration of
the stop preceding each walking bout (or previous stop
duration [PSD]).
The cumulated-time from the beginning of the stroll
(including durations of walking and stopping) was calcu-
lated as an indirect estimation of fatigue. Because the final
walking bout for the patients corresponded with the arrival
to their cars and not necessarily to lower limb pain, both the
last walking distance and the walking speed over the final
walking bout, as well as the stop duration preceding this
final walking bout, were not taken into account for subse-
quent analysis.
The expression WDBS was used to avoid possible con-
fusion with the MWD observed on the GPS recording
(MWDGPS). MWDGPS was the maximal value among the
different WDBS values.
Exclusion criteria. If any unexpected event was re-
ported on the post-test questionnaire, the patient was
excluded from the study. Furthermore, we expected that
some patients would not strictly follow the required 10-
minute pretest waiting period. After GPS data processing,
patients who did not stop for a minimal resting time before
the beginning of the stroll were excluded. This minimal
resting time was a priori and arbitrarily fixed at 2 minutes.
Statistical analysis. All data are expressed as mean
(standard deviation) or number and percentage. Between-
groups differences were compared using the 2 test, and
two-sample t tests for categoric and continuous variables,
respectively. Although we included only patients reporting
claudication, we expected that some patients would show a
limited number of stops. A minimal NWB of 5 was arbi-
imb p
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WDBS variability and further analysis. The magnitude of
variability for each parameter was expressed as the coeffi-
cient of variation (CV).
A step-by-step multivariate linear regression analysis
with stepwise selection was performed to search for a pre-
dictor parameter associated with WDBS. In our model,
WDBS was the dependent variable. The value for predictor
(independent) parameters to enter and stay in the model
was set at P  .10. The predictor parameters included into
the model were the negative exponential transformation of
walking speed during each walking bout (ExpV), the
logarithm transformation of PSD (log-PSD), and the cu-
mulated time. The rationales for those choices are pre-
sented in the Discussion.
In a multivariate analysis, a positive or negative  value
means a positive or inverse relationship between the depen-
dent variable and a predictor (independent) parameter,
respectively. The  coefficients were normalized to percent-
age values and, when significant, were an estimation of the
relative participation of the predictor parameter to the
variable to be explained by the model.
For all statistical tests, a two-tailed probability level of
P  .05 was used to indicate statistical significance. SPSS
15.0 software (SPSS Inc, Chicago, Ill) was used for all
statistical analyses.
Sample size estimation. Sample size estimation was
calculated according to our first goal, which was an estima-
tion of WDBS variability. We hypothesized that the mean
(SD) for the CV of WDBS was 50% (30%) and defined the
absolute acceptable error for the estimation of mean to
10%. Sample size calculation showed that 36 recordings
were required. There is low relationship between self-
reported MWD and objective measurements of walking
distance.7-9 Further, MWDGPS is an average of about three
Fig 1. Flow diagram of studied patients with peripher
subgroups of analyzed participants, and associated comp
variation; GPS, global positioning system; MWD, maxi
walking distance between two stops (induced by lower-ltimes higher than treadmill MWD.10 Last, because testswere performed in a public area and were not supervised,
we expected that some patients would be excluded due to
interfering events or to deviations from the recommenda-
tions for the walk. We therefore anticipated that many of
the included patients would have5 NWB. Inclusions were
performed until we had 36 patients with NWB  5.
RESULTS
As expected, 71 inclusions were required to reach the
36 patients necessary to allow for WDBS variability estima-
tion (Fig 1). Among these 71 PAD patients, 14 were
excluded (Table II, right column): 11 for reported stops
unrelated to leg pain during the walking stroll (urinating,
dizziness, looking at birds) and 3 other patients did not
stop for a minimum of 2 minutes before the beginning of
the stroll. The remaining 57 studied PAD patients were 47
men and 10 women (Table II, left column). Characteristics
of included patients were not significantly different from
excluded patients.
GPS results in included participants. Table III pre-
sents patient characteristics as well as GPS computed results
in two subgroups of PAD patients. After the analysis of GPS
recordings, among the 57 studied PAD patients, 21 had
NWB5 and 36 had NWB5. As expected, the 36 patients
with NWB 5 were more severe in term of self-reported
MWD, treadmill MWD, and ABI than the 21 patients with
NWB 5. In agreement with these laboratory measure-
ments of walking capacity, GPS computed results showed
that MWDGPS was higher in patients with NWB 5 com-
pared with patients with NWB 5 (Table III).
Variability result. All further results are calculated
only in the 36 patients with NWB 5. Table IV presents
results for individual WDBS, walking speed, and PSD. The
mean WDBS observed for each patient was 295 (226)
erial disease (PAD) shows included/excluded patients,
arameters. ABI, ankle-brachial index; CV, coefficient of
alking distance; PSD, previous stop duration; WDBS,
ain).al art
uted p
mal wmeters. WDBSwas variable within each stroll in all patients.
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individual values for WDBS variability were 10% and 123%.
The mean individual walking speed throughout the
stroll was 3.79 (0.67) km/h. Contrary toWDBS, speed was
relatively constant throughout the stroll for each patient.
The mean individual CV of speed among the different
bouts was 7% (range, 1%-17%).
The mean PSD in these 36 patients was 2.1 (1.8)
minutes. Most patients had short stops (3 minutes),
whereas one patient showed multiples stops that lasted
almost 10 minutes each. The durations of stops widely
varied during the stroll for each patient. The mean individ-
ual CV for PSD was 57% (35%) and superior to 22 in all the
patients.
Individual multivariate regression analysis. Fig 2
presents individual results for the multivariate analysis in
the 36 patients with NWB 5. As shown, log-PSD was
found in 16 patients as the predictor parameter in the
multivariate analysis. Cumulated time was associated to
WDBS in five other patients. Walking speed was never
found as a predictor parameter to WDBS. In the remaining
15 patients, no significant correlation was found, either as a
result of low r values despitemultiple walking bouts or of an
insufficient number of bouts to reach significance despite a
high r value (Fig 2). This is also why the multivariate
analysis was not performed in patients with NWB 5.
An example of GPS recording with PSD as the predic-
Table II. Characteristics of studied and excluded
patients with peripheral arterial disease (PAD)
Characteristic Studied Excluded Pa
PAD patients, No. 57 14
Age, mean (SD), y 59 (11) 61 (11) .67
Female sex, No. (%) 10 (18) 13 (7) .34
Height, mean (SD), cm 168 (6) 168 (7) .87
Weight, mean (SD), kg 79 (14) 82 (14) .43
Comorbidities, (history of),
No. (%)
Coronary disease 13 (23) 4 (29) .65
Stroke 2 (4) 0 .48
Chronic bronchitis 9 (16) 0 .11
Vascular surgery 21 (37) 2 (14) .11
Medications, No. (%)
Anticholesterol 45 (79) 11 (79) .87
Oral antidiabetic 11 (19) 3 (21) .87
Insulin 3 (5) 2 (14) .45
Antihypertensive 33 (58) 8 (57) .88
-blocker 19 (33) 5 (36) .88
Antiplatelet 53 (93) 13 (93) .85
Anticoagulant 1 (2) 1 (7) .49
Vasodilator 23 (40) 3 (21) .35
Self-reported MWD, mean
(SD), m 449 (517) 464 (535) .93
MWD-TT, mean (SD), m 174 (104) 168 (92) .85
Lowest rest ABI, mean (SD) 0.66 (0.19) 0.54 (0.20) .06
ABI, Ankle-brachial index; MWD, maximal walking distance; SD, standard
deviation; TT, treadmill test.
aP values represent 2 for categoric variables and two-sample t test for
continuous variables.tor parameter is presented in Fig 3. As shown, theWDBS toPSD relationship is clearly not linear, underlying the inter-
est of the logarithm transformation.
DISCUSSION
To our knowledge, this is the first application study
using GPS to approach new insights (walking speed, cumu-
lated time, PSD) into walking impairment in PAD patients
during a free-living, community-based outdoor walking.
The 43% CV found for the short-term variability of WDBS
during each stroll is larger than the 15% to 30% test-retest
CV generally reported for MWD in PAD patients.1-6 We
believe this is also the first study to report PSD as the
dominant parameter associated to WDBS.
Previous studies have shown the GPS technique is an
accurate tool to detect walking and stopping bouts and
estimate the walking speed and the distance between two
Table III. Characteristics of peripheral arterial disease
patients (PAD) and global positioning system-computed
results in the PAD patients showing 5 walking bouts
(NWB) and those showing at 5 NWB during the stroll
Characteristic
NWB per patient, No.
Pa5 5
PAD patients, No. 21 36
Age, mean (SD), y 61 (11) 58 (10) .23
Female sex, No. (%) 5 (24) 5 (14) .34
Height, mean (SD), cm 166 (5) 168 (7) .23
Weight, mean (SD), kg 74 (11) 81 (15) .06
Comorbidities, (history
of), No. (%)
Coronary disease 5 (24) 8 (22) .89
Stroke 1 (5) 1 (3) .70
Chronic bronchitis 4 (19) 5 (14) .61
Vascular surgery 6 (29) 14 (39) .43
Treatments, No. (%)
Anticholesterol 16 (76) 29 (81) .70
Oral antidiabetic 4 (19) 7 (19) .97
Insulin 2 (10) 1 (3) .27
Antihypertensive 11 (52) 23 (64) .39
-blocker 7 (33) 12 (33) 1.00
Antiplatelet 20 (95) 34 (94) .90
Anticoagulant 0 1 (3) .44
Vasodilator 9 (43) 15 (42) .93
Self-reported MWD,
mean (SD), m 690 (649) 315 (374) .01
MWD by TT, mean
(SD), m 223 (150) 145 (48) .01
Lowest rest ABI, mean
(SD) 0.73 (0.13) 0.62 (0.20) .03
GPS computed results,
mean (SD)
NWB 3 (2) 13 (7) .001
Stroll duration, min 59.0 (8.6) 65.5 (11.1) .02
Stroll total distance, m 3408 (824) 2819 (1036) .02
Walking speed, km/h 3.79 (0.51) 3.78 (0.65) .92
MWD by GPS, m 1905 (1189) 550 (621) .001
ABI, Ankle-brachial index; GPS, global positioning system;MWD,maximal
walking distance; TT, treadmill test.
aP values represent 2 test for categoric variables and two-sample t test for
continuous variables.stops in healthy participants.16 Afterward, we showed that
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sured on treadmill (r  0.81) in PAD patients with inter-
mittent claudication.10
The log-PSD in most patients was the predictor
parameter for WDBS. Although the time required for
physiologic parameters to recover is longer if workload is
increased,17,18 when PAD patients walk to maximal claudi-
cation pain on a treadmill, dissipation of pain during recov-
Table IV. Results from global positioning system
recording in the 36 peripheral arterial disease patients
showing 5 walking bouts during the stroll
Variable Mean (SD) Range
WD between pain-induced stops
Individual means, m 295 (226) 78-1158
Individual CV, % 43 (28) 10-123
Walking speed over each bout
Individual means, km/h 3.79 (0.67) 2.54-5.39
Individual CV, % 7 (4) 1-17
Previous stop duration
Individual means, min 2.1 (1.8) 0.4-9.2
Individual CV, % 57 (35) 22-209
CV, Coefficient of variation; SD, standard deviation;WD, walking distance.
Fig 2. Individual results from the multivariate analysis are shown
for the 36 participants with 5 NWB. One bar represents one
participant, bars are presented in decreasing values of absolute r.
PSD, Previous stop duration. The absolute r value is presented for
each individual (r is negative for cumulated time) and the explan-
atory parameter found in the multivariate analysis (specific color or
pattern). Facing each bar is the number of walking bouts during
the stroll. Note that white bars represent nonsignificant results and
that walking speed was never found as an explanatory parameter to
WDBS.ery is similar whether the preceding treadmill exercise isperformed at relatively low or high intensities.19 Inversely,
a plateau of forthcoming WDBS is expected when PSD is
increased, hence the use of log-PSD in the analysis. It is
expected that if patients start walking immediately after
pain relief, physiologic parameters are not normalized and
that the next walking bout will have to be stopped sooner.
This is consistent with the observations that the distance
walked at usual speed until a predefined 1-minute stop is
higher than the second distance performed after the
stop.20,21
In the present study, a negative relationship was ob-
served in 5 patients between WDBS and cumulated time.
Assuming that cumulated time is an acceptable tool for
fatigue estimation, our interpretation is that fatigue was
interfering with the walking capacities in these patients.
More than half of PAD patients walk3.2 km/w;22 there-
fore, a 1-hour stroll for most PAD patients, even at a
leisurely pace, represents an unusually long walk in itself.
Longer walks (eg, 2 hours) would probably have decreased
the proportion of patients with NWB5, but we estimated
that many patients would not have completed such a long
walk.
The underlying mechanisms of fatigue are still debated23-25
and induce unstable and slowed gait rhythm.26 PAD patients
respond to claudication pain by reducing preferred walking
speed and step length.27 The effect of fatigue during pro-
longed walking has not been studied in PAD patients.
A negative exponential relationship exists between
MWD and treadmill exercise intensity.3,19,28 The average
speed in our volunteers corresponded with the segment of
this relationship where any small intensity (speed) change
should result in a wide distance (WDBS) change.3 Then,
walking speed could be expected to be a dominant predic-
tor parameter of WDBS, and walking speeds should show
an inverse relationship to WDBS (positive  value for
ExpV). This was not the case. The absence of a relation-
ship between walking speed andWDBS does not mean that
if our patients had voluntarily walked fast, their WDBS
would not have decreased. We assume that the absence of
negative relationship between WDBS and speed resulted
from the patients’ average speed being relatively stable
throughout the stroll or from fatigue (and the potentially
associated decreased speed) interfering with the inverse
relationship searched between WDBS and speed.
Study limitations. From a statistical point of view, the
number of walking bouts per participant was small and thus
allowed at best for only one parameter per participant to be
statistically associated withWDBS. Additional data for each
volunteer could have been obtained by having the patients
perform multiple strolls. However, this would have mixed
two different concepts—short-term variability and test-
retest variability—and would not have allowed for the
analysis of the effect of cumulated time on walking capacity.
It could be suggested that cumulated time is only a medi-
ocre way of estimating fatigue and that there is no neces-
sary, linear association between this and WDBS. Lastly, the
statistical association of WDBS with the parameters studied
f var
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variables.
From a technical point of view, we only studied the
distance to pain-induced stops and not the distance to the
onset of limb discomfort. Nevertheless, walking distance at
maximal leg pain is generally preferred to distance at the
onset of pain.2,3,5 Unexpected external events led to the
exclusion of 3 patients. We cannot totally rule out that
other patients did not report them, thereby amplifying their
WDBS variability. At times, this might also be the reason
for the absence of association between WDBS and studied
parameters. Nevertheless it is unlikely that unreported
events, if present, changed the dominant parameter ob-
served because they would interfere in the same way over all
the studied parameters. Many potential confounding
parameters, including rain, wind, air temperature, and
changes in the level of ground, were not studied. Never-
theless, rainy and windy days were avoided for the present
study, which was performed in a flat park.
From a clinical point of view, there is no doubt that
many pathophysiologic mechanisms could account for the
short-term WDBS variability and remain to be studied.
Lastly, our patients’ WDBS variability, and potential deter-
minants of WDBS, might not necessarily reflect that of less
severe patients. This is true, but our goal was to have a
sufficient number of stops for each patient to allow the CV
calculation.
Clinical perspectives. Although the use of the GPS
technique in medicine is embryonic, particularly for vascu-
lar practice, the present study, together with our previous
study,10 provides interesting clinical perspectives. A GPS
recording could enable vascular specialists for whom tread-
mill testing is not readily accessible to have an objective
evaluation of a patient’s MWD, beyond the subjective
estimation through patient interview. Further, a number of
Fig 3. A typical example of a global positioning system
patient with peripheral arterial disease. CV, Coefficient ooriginal parameters related to the walking capacity can beprocessed, including walking speed (at the bout and stroll
level) or stopping duration, which are not readily accessible
even for physicians who do have a treadmill. Finally, the
GPS technique could be used as a Holter monitor in PAD
patients performing home-based exercise rehabilitation
programs. GPS might be helpful in determining compli-
ance during such programs and could be used to change
and adapt the training load throughout the rehabilitation
program.
CONCLUSIONS
The MWD is an index of the severity of PAD and a
key point for the therapeutic choices to be proposed to
PAD patients. In addition to the well-known test-retest
variability of MWD, we show here that a wide short-term
variability of WDBS exists during a single stroll. This
wide short-term variability of walking capacity may con-
tribute to the difficulties experienced by patients with
arterial claudication to estimate their so-called MWD at a
usual pace and could at least partly explain the low
concordance between estimated and measured MWD in
PAD patients.7-9
In most patients, WDBS is inversely related to the
duration of the stop that precedes each walking bout. This
suggests that early restart of walking, after pain relief, leads
to shortened walking capacity probably due to incomplete
ischemic recovery from the preceding walk. Whether PAD
patients with claudication should be asked to wait for a
minimal duration after the time of pain relief is an interest-
ing issue for future research studies.
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